Literature DB >> 27765626

The effect of sazetidine-A and other nicotinic ligands on nicotine controlled goal-tracking in female and male rats.

S Charntikov1, A M Falco2, K Fink2, L P Dwoskin3, R A Bevins4.   

Abstract

Nicotine is the primary addictive component of tobacco products and its complex stimulus effects are readily discriminated by human and non-human animals. Previous research with rodents directly investigating the nature of the nicotine stimulus has been limited to males. The current study began to address this significant gap in the literature by training female and male rats to discriminate 0.4 mg/kg nicotine from saline in the discriminated goal-tracking task. In this task, access to sucrose was intermittently available on nicotine session. On interspersed saline session, sucrose was not available. Both sexes acquired the discrimination as evidenced by increased head entries into sucrose receptacle (goal-tracking) evoked by nicotine; the nicotine generalization curves were also similar between females and males. The pharmacological profile of the nicotine stimulus was assessed using substitution and targeted combination tests with the following ligands: sazetidine-A, PHA-543613, PNU-120596, bupropion, nornicotine, and cytisine. For females and males, nornicotine fully substituted for the nicotine stimulus, whereas sazetidine-A, bupropion, and cytisine all evoked partial substitution. Female and male rats responded in a similar manner to interaction tests where a combination of 1 mg/kg of sazetidine-A plus nicotine or nornicotine shifted the nicotine dose-effect curve to the left. The combination of sazetidine-A plus bupropion or cytisine failed to do so. These findings begin to fill a significant gap the in scientific literature by studying the nature of the nicotine stimulus and response to therapeutically interesting combinations using a model that includes both sexes. Copyright Â
© 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acetylcholine; Drug discrimination; Interoceptive stimulus; Nicotine dependence; Pavlovian conditioning; Smoking; Tobacco

Mesh:

Substances:

Year:  2016        PMID: 27765626      PMCID: PMC5148659          DOI: 10.1016/j.neuropharm.2016.10.014

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  60 in total

1.  Nicotine self-administration in rats: estrous cycle effects, sex differences and nicotinic receptor binding.

Authors:  E C Donny; A R Caggiula; P P Rowell; M A Gharib; V Maldovan; S Booth; M M Mielke; A Hoffman; S McCallum
Journal:  Psychopharmacology (Berl)       Date:  2000-09       Impact factor: 4.530

Review 2.  Neuropharmacology of the interoceptive stimulus properties of nicotine.

Authors:  Thomas E Wooters; Rick A Bevins; Michael T Bardo
Journal:  Curr Drug Abuse Rev       Date:  2009-09

3.  Sex differences in the contribution of nicotine and nonpharmacological stimuli to nicotine self-administration in rats.

Authors:  Nadia Chaudhri; Anthony R Caggiula; Eric C Donny; Sheri Booth; Maysa A Gharib; Laure A Craven; Shannon S Allen; Alan F Sved; Kenneth A Perkins
Journal:  Psychopharmacology (Berl)       Date:  2005-01-29       Impact factor: 4.530

4.  Influence of sex and female hormones on nicotine-induced changes in locomotor activity in rats.

Authors:  L Kanýt; I P Stolerman; C J Chandler; T Saigusa; S Pöğün
Journal:  Pharmacol Biochem Behav       Date:  1999-01       Impact factor: 3.533

5.  The pharmacological activity of nicotine and nornicotine on nAChRs subtypes: relevance to nicotine dependence and drug discovery.

Authors:  Roger L Papke; Linda P Dwoskin; Peter A Crooks
Journal:  J Neurochem       Date:  2007-01-04       Impact factor: 5.372

6.  Asymmetric generalization between the discriminative stimulus effects of nicotine and cocaine.

Authors:  R I Desai; D J Barber; P Terry
Journal:  Behav Pharmacol       Date:  1999-11       Impact factor: 2.293

Review 7.  Nicotine discrimination in men and women.

Authors:  K A Perkins
Journal:  Pharmacol Biochem Behav       Date:  1999-10       Impact factor: 3.533

Review 8.  The subtypes of nicotinic acetylcholine receptors on dopaminergic terminals of mouse striatum.

Authors:  Sharon R Grady; Outi Salminen; Duncan C Laverty; Paul Whiteaker; J Michael McIntosh; Allan C Collins; Michael J Marks
Journal:  Biochem Pharmacol       Date:  2007-07-27       Impact factor: 5.858

9.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Authors:  Outi Salminen; Karen L Murphy; J Michael McIntosh; John Drago; Michael J Marks; Allan C Collins; Sharon R Grady
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

10.  Nicotine, tobacco use, and the 55th Nebraska Symposium on Motivation.

Authors:  Rick A Bevins; Anthony R Caggiula
Journal:  Nebr Symp Motiv       Date:  2009
View more
  11 in total

1.  Assessment of individual differences in response to acute bupropion or varenicline treatment using a long-access nicotine self-administration model and behavioral economics in female rats.

Authors:  Theodore Kazan; Christopher L Robison; Nicole Cova; Victoria M Madore; Sergios Charntikov
Journal:  Behav Brain Res       Date:  2020-02-25       Impact factor: 3.332

2.  Menthol blunts the interoceptive discriminative stimulus effects of nicotine in female but not male rats.

Authors:  Y Wendy Huynh; Anthony Raimondi; Andrew Finkner; Jordan D Kuck; Carly Selleck; Rick A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2020-05-24       Impact factor: 4.530

3.  Individual differences in responding to bupropion or varenicline in a preclinical model of nicotine self-administration vary according to individual demand for nicotine.

Authors:  Theodore Kazan; Sergios Charntikov
Journal:  Neuropharmacology       Date:  2019-01-03       Impact factor: 5.250

4.  Exploring the interoceptive stimulus effects of nicotine and varenicline.

Authors:  Brady M Thompson; Scott T Barrett; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2019-04-04       Impact factor: 3.533

5.  Understanding the stimulus effects of nicotine and bupropion in a drug-drug discriminated goal-tracking task.

Authors:  Andrea E Moran; Y Wendy Huynh; Andrew P Finkner; Carly Selleck; Aelyn Thompson; Scott T Barrett; Rick A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2022-02-09       Impact factor: 4.530

6.  The importance of acquisition learning on nicotine and varenicline drug substitution in a drug-discriminated goal-tracking task.

Authors:  Brady M Thompson; Scott T Barrett; Y Wendy Huynh; David A Kwan; Jennifer E Murray; Rick A Bevins
Journal:  Pharmacol Biochem Behav       Date:  2020-10-12       Impact factor: 3.533

7.  The effect of N-acetylcysteine or bupropion on methamphetamine self-administration and methamphetamine-triggered reinstatement of female rats.

Authors:  Sergios Charntikov; Steven T Pittenger; Cindy M Pudiak; Rick A Bevins
Journal:  Neuropharmacology       Date:  2018-03-28       Impact factor: 5.250

8.  Effects of nicotine conditioning history on alcohol and methamphetamine self-administration in rats.

Authors:  Patrick A Randall; Brayden Fortino; Y Wendy Huynh; Brady M Thompson; Christopher E Larsen; Mackenzie P Callen; Scott T Barrett; Jennifer E Murray; Rick A Bevins; Joyce Besheer
Journal:  Pharmacol Biochem Behav       Date:  2019-01-19       Impact factor: 3.533

Review 9.  Interoception and alcohol: Mechanisms, networks, and implications.

Authors:  Dennis F Lovelock; Ryan E Tyler; Joyce Besheer
Journal:  Neuropharmacology       Date:  2021-09-23       Impact factor: 5.250

10.  Reward-enhancing effects of d-amphetamine and its interactions with nicotine were greater in female rats and persisted across schedules of reinforcement.

Authors:  Kathleen R McNealy; Margaret E Ramsay; Scott T Barrett; Rick A Bevins
Journal:  Behav Pharmacol       Date:  2021-08-01       Impact factor: 2.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.